I forbindelse med ledsagende indgivelse af Diacomit til børn med Dravets syndrom er der blevet indberettet cirka to - til tredobbelte stigninger i plasmaniveauerne af clobazam og femdobbelte stigninger i plasmaniveauerne af norclobazam.
Approximately two to three fold increases in clobazam and five fold increases in norclobazam plasma levels respectively have been reported with co- administration of Diacomit in children with Dravet’ s syndrome.